Are you safe?
EuroSafe Imaging is a wake-up call, an ambitious campaign launched by the European Society of Radiology (ESR) to increase awareness about the risks of radiation in medical imaging, but also to better promote the benefits of exams.
Congresses
The future of radiology: Art or science?
Two things that radiologists resist – structured reporting and (computer-assisted) quantification – are the very things that Gabriel Krestin believes are essential to advance diagnosis in the brave new world of omic-medicine that is emerging.
Russia: Scanners plentiful but radiologists too scant
However, investments in equipment and advanced training are attracting medical students, John Brosky reports
Overcoming the technical challenges
Digital breast tomosynthesis offers a number of benefits over other modalities but challenges remain in its optimum clinical application.
Validating imaging biomarkers
New imaging biomarkers are helping radiology to play a greater role in new drug developments.
MIR@ECR
Management in Radiology (MIR) is a subcommittee of the ESR Professional Organisation Committee, set up to address current challenges and provide a forum for education and the exchange of ideas and concepts.
‘Huge progress’ in the ICU
You’ll find Élie Azoulay everywhere during this year’s International Symposium on Intensive Care and Emergency Medicine (ISICEM).
CT developments far excel those for MRI
For the sixth time, Alain Blum MD has invited the French CT community to Nancy to attend a symposium on multi-detector CT. The last invitations, two years back, drew several hundred radiologists and every CT manufacturer to Nancy for two days of debate, discussion and demonstrations.
Virtual anatomy
In 2007, Sara Doll (Institute for Anatomy and Cell Biology, Heidelberg University) and Dr Frederik Giesel (Managing Senior Physician, Radiology Clinic, Department of Nuclear Medicine at Heidelberg University Hospital) initiated the development of virtual anatomy for a seminar aimed at students in the pre-clinical phase of their medical degree course.
A challenge for oncologists
‘The disease “cancer” is increasingly classified into sub-groups. Today, we are already dealing with a number of orphan diseases,’ says Professor Richard Greil MD, head of LIMCR at University Hospital Salzburg.
Pain is the point of departure for medical interaction
Pain is the point of departure of any medical interaction. When a body sends out pain signals to say that something is wrong, the person in pain will react – either by selfmedication or by consulting a physician.
Cross-border healthcare directive and patients’ rights
For the first time, the right of patients in Europe to seek healthcare in another Member State, and be reimbursed for it, is clearly established thanks to the EU Directive on Patients’ Rights in Cross-Border Healthcare. EPF organised a three-day regional conference to enable Patient leaders to understand the details of this legislation and its transposition at national level.
RSNA honours leading European radiologists
At the 99th Annual Meeting of the Radiological Society of North America (RSNA), two of Europe's leading radiologists were among the three recipients of the Honorary RSNA Membership Awards that recognize significant achievements in the field.
MEDICA and COMPAMED 2013 keeping pace with the market
Good international business contacts are becoming increasingly important for manufacturers of medical technology and medical products.
The 99th RSNA will open today
The “North America” is somewhat of a misnomer for the Radiological Society of North America. Of its 53,000+ members, 25% live and work in 138 countries outside North America.
Article • MEDICA 2013
Genetically targeted medicine forges ahead
Healthcare is undergoing a major change set to offer a real prospect of far more genetically targeted treatments, according a leading human geneticist Sir John Burn, Professor of Clinical Genetics at Newcastle University, England.
Endovascular thrombolysis
Neurologists keenly debate the value of mechanical reopening of blocked blood vessels in the brain, as demonstrated during the 21st World Congress for Neurology (WCN) in Vienna this September. Theoretically, endovascular thrombolysis can only be considered for 20-30% of all incidents of stroke.
Dutch innovation reaches out at MEDICA
The Task Force Health Care (TFHC) was initiated in 1996 by the private sector; the Dutch government acts as a partner.
Ultrasound in trauma and orthopaedics
At October’s annual congress of trauma and orthopaedic surgeons in Berlin, the session Ultrasound beyond trauma and orthopaedic surgery – What can we learn from neighbouring disciplines? exposed the unexploited potential of ultrasound for trauma and orthopaedic surgery, EH correspondent Bettina Döbereiner reports.
Vendors and providers have worked to make examinations safer
Nuclear medicine (NM) is the second largest source of medical radiation exposure after CT. However, patients who had a NM examination a decade ago most likely received a higher radiation dose than a patient in 2013.
New award to promote quality in radiology
Telemedicine Clinic, Europe’s leading teleradiology company, has launched the TMC Radiology Quality Award, a €10,000 prize to promote quality initiatives within European radiology.
The ultimate in ultrasound
A joint meeting combining the Euroson and Three Countries congresses creates a veritable European summit on the state-of-the-art in ultrasound
European Society of Cardiology: Best of ESC Congress 2013
We must not forget that despite advances, cardiovascular disease remains the number one killer in Europe.
Natural orifice translumenal endoscopic surgery
A record 1,700 participants from 84 countries confirmed the dimension and international importance of the European Association of Endoscopic Surgery Congress held recently in Vienna, where Hans-Christian Pruszsinsky caught up with Congress President Professor Selman Uranüs, Head of the Section for Surgical Research, Medical University of Graz, for our interview.
The 33rd German Society for Senology Congress
Like any other cancer – breast cancer is a highly individual disease, shaped by many factors such as age, health status or genetics. Due to the complex web of molecular pathological processes and resistance mechanisms it is very difficult to select the most effective therapy for each patient.
